ORTX
Undervalued by 2.7% based on the discounted cash flow analysis.
Market cap | $380.11 Million |
---|---|
Enterprise Value | $405.20 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.61 |
Beta | 0.55 |
Outstanding Shares | 22,838,856 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -8.01 |
---|---|
PEG | 31.11 |
Price to Sales | - |
Price to Book Ratio | 5.57 |
Enterprise Value to Revenue | 18.55 |
Enterprise Value to EBIT | 6.54 |
Enterprise Value to Net Income | 5 |
Total Debt to Enterprise | 0.12 |
Debt to Equity | 0.61 |
No data
No data